Mainz Biomed enhances PancAlert using AI for biomarker selection
globenewswire.com — September 4, 2024, 09:00 AM UTC
Summary: Mainz Biomed has expanded its collaboration with Liquid Biosciences to enhance biomarker selection for its PancAlert pancreatic cancer detection test using AI technology. The first phase showed promising results, leading to plans for a second phase that includes microbiome biomarkers. Pancreatic cancer has a global mortality rate of approximately 466,000 annually, with a 5-year survival rate of about 11% in the U.S.
Article metrics
The article metrics are deprecated.
I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.